Graviti Pharmaceuticals Private Limited recalls Furosemide Tablets
- Recalling company
- Graviti Pharmaceuticals Private Limited
- Product
- Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
- Reason
- Presence of Foreign Substance
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Jan 10, 2026
- Reported
- Jan 28, 2026
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 4212 bottles
- Lot / codes
- Lot# FUB125042G; Exp. 05/13/2027
- Company location
- Hyderabad
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0293-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0293-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.